Clinical experience with gefitinib: An update

Hidefumi Sasaki, Katsuhiko Endo, Akimitsu Konishi, Minoru Takada, Masaaki Kawahara, Keiji Iuchi, Akihide Matsumura, Meinoshin Okumura, Hisaichi Tanaka, Tomoya Kawaguchi, Toshiki Shimizu, Hiroshi Takeuchi, Motoki Yano, Ichiro Fukai, Yoshitaka Fujii, EGFR Mutation Status in Japanese Lung Cancer Patients: Genotyping Analysis Using LightCycler Clinical Cancer Research. ,vol. 11, pp. 2924- 2929 ,(2005) , 10.1158/1078-0432.CCR-04-1904

Jeremy N. Rich, David A. Reardon, Terry Peery, Jeannette M. Dowell, Jennifer A. Quinn, Kara L. Penne, Carol J. Wikstrand, Lauren B. Van Duyn, Janet E. Dancey, Roger E. McLendon, James C. Kao, Timothy T. Stenzel, B.K. Ahmed Rasheed, Sandra E. Tourt-Uhlig, James E. Herndon, James J. Vredenburgh, John H. Sampson, Allan H. Friedman, Darell D. Bigner, Henry S. Friedman, Phase II Trial of Gefitinib in Recurrent Glioblastoma Journal of Clinical Oncology. ,vol. 22, pp. 133- 142 ,(2004) , 10.1200/JCO.2004.08.110

Teh-Ying Chou, Chao-Hua Chiu, Ling-Hui Li, Chun-Yen Hsiao, Chin-Yuan Tzen, Kuo-Ting Chang, Yuh-Min Chen, Reury-Perng Perng, Shih-Feng Tsai, Chun-Ming Tsai, Mutation in the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor Is a Predictive and Prognostic Factor for Gefitinib Treatment in Patients with Non–Small Cell Lung Cancer Clinical Cancer Research. ,vol. 11, pp. 3750- 3757 ,(2005) , 10.1158/1078-0432.CCR-04-1981

Mark G. Kris, Ronald B. Natale, Roy S. Herbst, Thomas J. Lynch, Jr, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, Harris Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael K. Wolf, Steven D. Averbuch, Judith J. Ochs, Andrea C. Kay, Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial JAMA. ,vol. 290, pp. 2149- 2158 ,(2003) , 10.1001/JAMA.290.16.2149

William Pao, Theresa Y Wang, Gregory J Riely, Vincent A Miller, Qiulu Pan, Marc Ladanyi, Maureen F Zakowski, Robert T Heelan, Mark G Kris, Harold E Varmus, KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib PLOS Medicine. ,vol. 2, ,(2005) , 10.1371/JOURNAL.PMED.0020017

Antonio Marchetti, Carla Martella, Lara Felicioni, Fabio Barassi, Simona Salvatore, Antonio Chella, Pier P. Camplese, Teodorico Iarussi, Felice Mucilli, Andrea Mezzetti, Franco Cuccurullo, Rocco Sacco, Fiamma Buttitta, EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment Journal of Clinical Oncology. ,vol. 23, pp. 857- 865 ,(2005) , 10.1200/JCO.2005.08.043

J. Baselga, D. Rischin, M. Ranson, H. Calvert, E. Raymond, D.G. Kieback, S.B. Kaye, L. Gianni, A. Harris, T. Bjork, S.D. Averbuch, A. Feyereislova, H. Swaisland, F. Rojo, J. Albanell, Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types Journal of Clinical Oncology. ,vol. 20, pp. 4292- 4302 ,(2002) , 10.1200/JCO.2002.03.100

Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller, Ronald B. Natale, Vincent Miller, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Ira Oliff, James A. Reeves, Michael K. Wolf, Annetta D. Krebs, Steven D. Averbuch, Judith S. Ochs, John Grous, Abderrahim Fandi, David H. Johnson, Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 Journal of Clinical Oncology. ,vol. 22, pp. 785- 794 ,(2004) , 10.1200/JCO.2004.07.215

Pablo Matar, Federico Rojo, Raúl Cassia, Gema Moreno-Bueno, Serena Di Cosimo, José Tabernero, Marta Guzmán, Sonia Rodriguez, Joaquín Arribas, José Palacios, José Baselga, Combined Epidermal Growth Factor Receptor Targeting with the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225) Superiority Over Single-Agent Receptor Targeting Clinical Cancer Research. ,vol. 10, pp. 6487- 6501 ,(2004) , 10.1158/1078-0432.CCR-04-0870

G.L. Ceresoli, F. Cappuzzo, V. Gregorc, S. Bartolini, L. Crinò, E. Villa, Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial Annals of Oncology. ,vol. 15, pp. 1042- 1047 ,(2004) , 10.1093/ANNONC/MDH276